POSILAC- sometribove suspension

Riik: Ameerika Ühendriigid

keel: inglise

Allikas: NLM (National Library of Medicine)

Toimeaine:

sometribove (UNII: PBK5EQG5CQ) (sometribove - UNII:PBK5EQG5CQ)

Saadav alates:

Elanco US Inc.

Manustamisviis:

SUBCUTANEOUS

Retsepti tüüp:

OTC

Näidustused:

To increase production of marketable milk in healthy lactating dairy cows. CAUTION: Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.

Toote kokkuvõte:

Single-dose syringes in 25 or 100 count boxes. NADA#140-872 Approved by FDA Manufactured by Elanco US Inc. Greenfield, IN 46140 U.S.A. Questions or comments, please call 1-800-233-2999 Posilac, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates. Revised December 2017.

Volitamisolek:

New Animal Drug Application

Toote omadused

POSILAC- SOMETRIBOVE SUSPENSION
ELANCO US INC.
----------
ELANCO™
AH0225
POS ILAC™
DESCRIPTION:
Sterile, prolonged-release injectable formulation of a recombinant
DNA-derived bovine somatotropin
analog in single-dose syringes each containing 500 mg of sometribove
zinc.
USE:
To increase production of marketable milk in healthy lactating dairy
cows.
CAUTION: Federal law prohibits extra-label use of this drug to enhance
food and/or fiber production
in animals.
DOSAGE:
Inject one syringe of Posilac every 14 days. Start during the 9th or
10th week (57-70 days) after calving
and continue until the end of lactation.
ADMINISTRATION:
Allow syringes to warm to room temperature (15° to 30° C; 59° to
86° F) before use.
INJECTION TECHNIQUE:
Inject Posilac subcutaneously (under the skin). Recommended injection
sites are the _neck area, behind the_
_shoulder_ or in the _depression on either side of the tailhead_ (see
diagrams below). Alternate between the
cow's left and right side on consecutive injections. Remove surface
dirt from the injection site area
before injecting. Inject entire contents of the syringe
subcutaneously. Do not reuse syringes.
Inject directly into the deepest depressions on either side of the
tailhead (marked “Yes”). Avoid the
bone, muscles, tendons and ligaments of the tail and the rectal and
anal muscles. DO NOT INJECT INTO THE
CAUDAL FOLD (MARKED “NO”) BECAUSE THIS MAY INVALIDATE USDA
TUBERCULOSIS TESTING. Locate the
caudal fold by raising the tail.
INJECTION SITES:
HUMAN WARNINGS:
AVOID PROLONGED OR REPEATED CONTACT WITH POSILAC WITH EYES AND SKIN.
POSILAC IS A PROTEIN. FREQUENT SKIN CONTACT WITH PROTEINS MAY PRODUCE
AN ALLERGIC REACTION IN SOME
PEOPLE. ALWAYS WASH HANDS AND SKIN EXPOSED TO POSILAC WITH SOAP AND
WATER AFTER HANDLING.
CLOTHING SOILED WITH THE PRODUCT SHOULD BE LAUNDERED BEFORE REUSE.
For use in animals only.
Keep this and all medications out of the reach of children.
PRECAUTIONS AND SIDE EFFECTS:
Use in lactating dairy cattle only.
Safety to replacement bulls born in dai